Prot# SHH4812g: A Phase II, Multicenter, Open Label, Two-Cohort Trial Evaluating The Efficacy And Safety of GDC-0449 In Operable Basal Cell Carcinoma (BCC). DNA Repository Substudy in Association With GDC-0449 Study SHH4812g.

Project: Research project

StatusFinished
Effective start/end date1/13/111/13/14

Funding

  • PPD Development (SHH4812g)
  • Genentech, Inc. (SHH4812g)